According to Madrigal Pharmaceuticals 's latest financial reports the company's current earnings (TTM) are -C$0.68 B. In 2023 the company made an earning of -C$0.49 B a decrease over its 2022 earnings that were of -C$0.4 B.The earnings displayed on this page is the company's Pretax Income.